Saving Medicare Through Patient-centered Changes — The Case of Injectables

By Jeffrey S. Farroni, Leonard Zwelling, Jorge Cortes and Hagop Kantarjian

Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration.

Read the full article in The New England Journal of Medicine.